KC-459

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKC-459
Drug Alias NameASK/Cdc7 inhibitor (SBI Biotech)Cdc7/ASK inhibitor (SBI Biotech)Cdc7/ASK inhibitor (SBI Biotech/Carna Biosciences)KC-478KC-459
ClassificationSmall molecules
Mechanisms of ActionApoptosis signal-regulating kinase 1 inhibitorsCell cycle inhibitorsAnticancer protein kinase inhibitors +[4] 
TargetsApoptosis signal-regulating kinase 1Cell division cycle 7-related protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSbi Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSbi Biotech Co LtdCarna Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A